fbpx

Call now: 07 5408 0900

Coeliac Disease (CEL-4/CEL)

Capsule to Treat Refractory Coeliac Disease despite a gluten free diet

Study Title

A phase IIb, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of ZED1227 in celiac disease subjects experiencing symptoms despite gluten-free diet.

Purpose of Study

To assess 3 different doses and 2 different dosing schedules of ZED1227 capsules for efficacy in: improving duodenal mucosal and coeliac disease symptoms subjects experiencing symptoms and having mucosal damage despite gluten-free diet.

.

Eligibility

You may be eligible for the study if you meet the following criteria.

Please contact CDH Research Institute on 07 5408 0900 for additional information or use the email link below. You can also share details of this study to social media via the links below?

Facebook
Twitter
LinkedIn
Pinterest
Email
CDH Research Institute

Complete the form to register.

CDH Research Institute

Complete the form to register.